Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
MDA and CMTA Fund Grant to Study Gene Therapy in Charcot-Marie-Tooth Disease
…million. MDA and the CMTA are co-funding the grant under a partnership formed in 2016 that aims to advance CMT research, therapy development and clinical care, and increase understanding about…
Diagnosticando CMT
Diagnosticando CMT Charcot–Marie–Tooth, o CMT, es la neuropatía periférica hereditaria más común y se encuentra en todo el mundo entre todas las razas y grupos étnicos. Descubierto en 1886 por…
Nanoparticles for CMT1A, CMT1B, and CMTX1: A New Frontier in Gene Therapy
…Genetics are pioneering the use of nanoparticles to develop gene therapy approaches for three common types of CMT: CMT1A, CMT1B, and CMTX1 (also known as CMT1X or CMTX). The gene…
2021 CMTA Annual Report
Inherited Neuropathies Consortium Study 6603: Development of CMTPedS Scale for Children with CMT
The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the Inherited Neuropathy Consortium (INC), is proud to share this important opportunity for families living with Charcot-Marie-Tooth disease (CMT). This longitudinal…
2017_Winter_CMTA_Report
CMTA Report_Spring 2025_Download
CMTA_2020_Annual_Report
CMT Awareness Month 2022
…the clinical and research communities. CMT Awareness Week was born in September 2010, as the CMTA community began to educate others about CMT. Over the years, one special week morphed…